Device market access is fundamentally different from pharma. There is no formulary to win — instead, you face value analysis committees, hospital capital budgets, DRG and APC reimbursement alignment, GPO contracts, and surgeon preference dynamics. Each hospital system evaluates devices through its own governance process, and the evidence they require to approve a purchase is often different from what regulators required to clear the device.
Behavior Labs delivers market access decision intelligence purpose-built for medical devices — connecting reimbursement pathway analysis, value analysis committee modeling, hospital budget impact assessment, and GPO contract intelligence into a compounding platform that transforms market access from an ad hoc function into a systematic strategic capability.
The gap between regulatory clearance and commercial adoption is where most device programs stall. Market access intelligence bridges that gap by modeling the economic, clinical, and organizational dynamics that drive hospital purchasing decisions.
Model VAC decision dynamics across hospital systems — committee composition, evidence requirements, evaluation criteria, and approval patterns. Understand what each VAC needs to see and prepare submissions that address their specific requirements.
Navigate DRG and APC code alignment, new technology add-on payments (NTAP), transitional pass-through payments, and coverage with evidence development (CED) pathways. Model the reimbursement landscape that determines whether hospitals can afford your device.
Quantify the total cost of ownership, procedure volume projections, training requirements, and capital depreciation schedules that drive hospital budget decisions. Build economic models that speak the language of CFOs and supply chain directors.
Track GPO contract structures, committed volume tiers, compliance rates, and competitive pricing intelligence. Model contract scenarios that optimize market share while maintaining margin across different distribution channels.
The path from clearance to commercial adoption depends on market access intelligence that most device companies build ad hoc.
See how lifecycle decision intelligence transforms device market access from ad hoc preparation to systematic strategic advantage.
